Literature DB >> 18023024

Liver disease in adolescents: A cohort study of high-risk individuals.

David Van der Poorten1, Dianna T Kenny, Tony Butler, Jacob George.   

Abstract

UNLABELLED: Little is known about the health and behavior of adolescent offenders as they relate to abnormalities of liver biochemistry and hepatitis C virus (HCV) infection. A large study of male juvenile offenders was undertaken that allowed a re-evaluation of the normal limits of alanine aminotransferase (ALT), associations with elevated ALT, and HCV antibody positivity. Young offenders (age 12-19 years) serving community orders participated in a wide-ranging health survey and laboratory assessment between October 2003 and December 2005. Normal ranges for liver biochemistry were calculated from the 95th percentile of males at the lowest risk for liver disease. The final sample comprised 682 males, of whom 439 (64%) gave blood. The calculated upper limit of normal for ALT was 28 IU/L. Seventeen percent of adolescents had an elevated ALT. Strong associations with elevated ALT included HCV antibody positivity [odds ratio (OR) 14.6], overweight and obesity (OR 6.9), and elevated total cholesterol (OR 3.6). More than 90% of adolescents with elevated ALT levels had 1 or more features of the metabolic syndrome. HCV antibody was positive in approximately 3% of the cohort, with the most significant risk factor being injecting drug use (OR 7.8; P < 0.01). The new infection rate was 3.7% per year.
CONCLUSION: New upper limits for ALT provide greater sensitivity for the early diagnosis of liver disease in adolescents. High rates of HCV infection and obesity-related liver disease exist in this group, and targeted interventions are needed to reduce future health-related morbidity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023024     DOI: 10.1002/hep.21918

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Impact of weight-loss surgery and diabetes status on serum ALT levels.

Authors:  Dimitrios Xourafas; Ali Ardestani; Stanley W Ashley; Ali Tavakkoli
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat.

Authors:  Sraboni Sarkar; Xin Mao; Chuang Liu; Sulie L Chang
Journal:  Alcohol Clin Exp Res       Date:  2012-07-23       Impact factor: 3.455

Review 3.  Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review.

Authors:  Shadi Kolahdoozan; Babak Mirminachi; Sadaf G Sepanlou; Reza Malekzadeh; Shahin Merat; Hossein Poustchi
Journal:  Middle East J Dig Dis       Date:  2020-07

4.  Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Perrie E Pardee; Joel E Lavine; Aaron K Blumkin; Stephen Cook
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

5.  Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.

Authors:  Hossein Poustchi; Jacob George; Saeed Esmaili; Farzaneh Esna-Ashari; Gelayol Ardalan; Sadaf Ghajarieh Sepanlou; Seyed Moayed Alavian
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

6.  Predicting Liver Disease Risk Using a Combination of Common Clinical Markers: A Screening Model from Routine Health Check-Up.

Authors:  Yi Wang; Yanni Li; Xiaoyi Wang; Ranko Gacesa; Jie Zhang; Lu Zhou; Bangmao Wang
Journal:  Dis Markers       Date:  2020-05-31       Impact factor: 3.434

7.  Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.

Authors:  Ming-Hua Zheng; Ke-Qing Shi; Yu-Chen Fan; Wen-Yue Liu; Xian-Feng Lin; Ling-Fei Li; Yong-Ping Chen
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

Review 8.  Alanine aminotransferase-old biomarker and new concept: a review.

Authors:  Zhengtao Liu; Shuping Que; Jing Xu; Tao Peng
Journal:  Int J Med Sci       Date:  2014-06-26       Impact factor: 3.738

Review 9.  Primary and secondary prevention of liver cancer caused by HBV.

Authors:  Baruch S Blumberg
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.